Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CM-MIE for Encopresis in Autistic Youth
NCT07226739Phase 4Recruiting
- Sponsor
- Emory University
- Start
- Jun 2026
- Primary completion
- Jan 2031
- Modality
- Implantable Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in encopresis (2 arms), sponsored by Emory University. Primary endpoint: Clinical Global Impression Improvement at 5 weeks. Started Jun 2026; status: recruiting.
02
Conditions
encopresis
Beyond the preview
Go deeper on NCT07226739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07226739.